Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Systemic Arteries

Overview of Systemic Arteries

The human body is a complex, well-organized machine, and at the heart of its operations lies the circulatory system. This network of blood vessels, which includes systemic arteries, plays a vital role in maintaining life by transporting nutrients, oxygen, and waste products to and from cells throughout the body.
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the heart.

Overview of Systemic Veins

Overview of Systemic Veins

Systemic veins are crucial blood vessels that return deoxygenated blood from various body tissues back to the heart. There are three systemic veins that return deoxygenated blood to the heart, they are as follows.
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the middle...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...

Pericarditis III: Medical Management

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimizing Strategies for Managing Difficult Intravenous Access.

Risk management and healthcare policy·2025

Same author

Exploring the role of Artificial Intelligence in Acute Kidney Injury management: a comprehensive review and future research agenda.

BMC medical informatics and decision making·2024

Same author

Point-of-care ultrasound training in nephrology: a position statement by the International Alliance for POCUS in Nephrology.

Clinical kidney journal·2024

Same author

Impact of specialized renal technologists on optimizing delivery of continuous kidney replacement therapy in critical care areas a retrospective study.

Hemodialysis international. International Symposium on Home Hemodialysis·2024

Same author

Barriers Preventing Medical Trainees from Active Participation in Research Activities.

Journal of multidisciplinary healthcare·2024

Same author

Capacity for the management of kidney failure in the International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).

Kidney international supplements·2024

Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026

Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026

Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026

Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026

Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026

Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 29, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Update on systemic vasculitides.

Siddiq Anwar¹, M Yousuf Karim²

¹Department of Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.

Journal of Clinical Pathology

|April 6, 2017

Summary

This summary is machine-generated.

Systemic vasculitis management has improved with targeted biological agents. Optimal use of these costly treatments is crucial for remission, relapse prevention, and improved quality of life.

Keywords:

ANTIBODIES AUTOANTIBODY IMMUNOLOGY LYMPHOCYTES VASCULITIS

More Related Videos

Rodent Inferior Vena Cava Venoplasty Balloon Model

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Experiment Videos

Last Updated: Jun 29, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Rodent Inferior Vena Cava Venoplasty Balloon Model

Rodent Inferior Vena Cava Venoplasty Balloon Model

Published on: May 24, 2024

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Area of Science:

Rheumatology and Immunology
Internal Medicine

Background:

Systemic vasculitis management has been transformed by targeted biological agents.
Increased prevalence and recognition of vasculitis necessitate optimal treatment utilization.
High costs of biological agents require careful consideration for effective patient outcomes.

Purpose of the Study:

To review recent advances in the diagnosis of systemic vasculitis.
To discuss current surveillance strategies for vasculitis patients.
To highlight novel treatment approaches for systemic vasculitis.

Main Methods:

Literature review of recent advancements in vasculitis diagnosis.
Analysis of current surveillance techniques for managing vasculitis.
Synthesis of data on emerging biological agents and therapeutic strategies.

Main Results:

Biological agents have significantly improved vasculitis management outcomes.
Optimal utilization strategies are key to maximizing treatment benefits.
Advances in diagnosis and surveillance aid in early detection and monitoring.

Conclusions:

Targeted biological agents represent a major advancement in systemic vasculitis therapy.
Effective management requires a focus on achieving and maintaining remission while minimizing toxicity.
Ongoing research into diagnosis, surveillance, and treatment is vital for improving patient quality of life and reducing mortality.